Drugs / SB injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01305967 | Jan 2003 → May 2011 | non-small cell lung carcinoma | SBPharmaceutical IND, Co., LTD | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SB injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01305967 ↗ |
| Route | Intravenous | “Intravenous route” NCT01305967 ↗ |